Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection
Coronavirus disease 2019 (COVID-19) is caused by a novel virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2-induced hyperinflammation together with alteration of plasma proteins, erythrocyte deformability, and platelet activation, may affect blood viscosity. Thus...
Main Authors: | Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Sadiq M. Al-Hamash, Simona Cavalu, Maisra M. El-Bouseary, Fatma I. Sonbol, Gaber El-Saber Batiha |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.876017/full |
Similar Items
-
The potential molecular implications of adiponectin in the evolution of SARS-CoV-2: Inbuilt tendency
by: Hayder M. Al-Kuraishy, et al.
Published: (2022-11-01) -
Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer
by: Gaber El-Saber Batiha, et al.
Published: (2022-11-01) -
The potential role of scavenger receptor B type I (SR‐BI) in SARS‐CoV‐2 infection
by: Luay Alkazmi, et al.
Published: (2023-04-01) -
New insights on the potential effect of progesterone in Covid‐19: Anti‐inflammatory and immunosuppressive effects
by: Hayder M. Al‐Kuraishy, et al.
Published: (2023-11-01) -
Janus kinase inhibitors in immunoinflammatory rheumatic diseases
by: Evgeny L. Nasonov
Published: (2022-06-01)